Mirae Asset Global Investments Co., Ltd. Cara Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$0.52 - $1.05 $11,031 - $22,274	21,214 New	21,214 $19,000
Q2 2023 Aug 10, 2023	SELL	$2.83 - $4.94 $297 - $518	-105 Reduced 0.47%	22,434 $63,000
Q1 2023 May 04, 2023	SELL	$4.89 - $12.27 $171 - $429	-35 Reduced 0.16%	22,539 $110,000
Q4 2022 Feb 09, 2023	BUY	$8.88 - $12.77 $24,606 - $35,385	2,771 Added 13.99%	22,574 $242,000
Q3 2022 Nov 10, 2022	BUY	$8.24 - $12.56 $47,412 - $72,270	5,754 Added 40.96%	19,803 $186,000
Q2 2022 Jul 26, 2022	BUY	$7.45 - $13.84 $104,665 - $194,438	14,049 New	14,049 $128,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $247M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.